Bare platinum vs matrix detachable coils for the endovascular treatment of intracranial aneurysms: a multivariate logistic regression analysis and review of the literature. Academic Article uri icon

Overview

abstract

  • BACKGROUND: Despite increasing acceptance of endovascular coiling for treating intracranial aneurysms, incomplete occlusion remains a limitation. Attempts to reduce recanalization have prompted creation of polyglycolic/polylactic acid-coated (Matrix) coils shown to improve neointima formation; however, previous publications demonstrate conflicting results regarding their efficacy. Few studies account for factors influencing recurrence, and only 4 studies include bare platinum (BP) coil control groups. OBJECTIVE: To compare initial and short- and mid-term occlusion as well as retreatment rates using Matrix compared with BP coils. METHODS: Retrospective review of patients undergoing coiling of cerebral aneurysms from 2001 to 2005 was performed. Analysis included a multivariate logistic regression model designed to detect a 35% absolute difference in initial occlusion between coil treatment groups with 80% power. RESULTS: Complete initial occlusion was achieved in 64% of BP (n = 45) and 63% of Matrix (n = 56) cases (P = 1.0). Follow-up occlusion rates in the short term and mid term were 52% and 60%, respectively, for BP cases and 42% and 67%, respectively, for Matrix cases (P = .24 and P = .38, respectively). After adjusting for size, morphology, volumetric packing density, location, rupture, and balloon remodeling, no difference in initial and subsequent occlusion or retreatment rates for BP coils versus Matrix coils was appreciated. CONCLUSION: After controlling for factors influencing recanalization, this investigation failed to show a significant difference between coil groups.

publication date

  • September 1, 2011

Research

keywords

  • Coated Materials, Biocompatible
  • Endovascular Procedures
  • Intracranial Aneurysm
  • Lactic Acid
  • Neurosurgical Procedures
  • Platinum
  • Polyglycolic Acid

Identity

Scopus Document Identifier

  • 80051783906

Digital Object Identifier (DOI)

  • 10.1227/NEU.0b013e31821a86da

PubMed ID

  • 21499161

Additional Document Info

volume

  • 69

issue

  • 3